This article may require copy editing for grammar, style, cohesion, tone, or spelling. You can assist by editing it. (April 2013)
Systematic (IUPAC) name
carboxylic acid methyl ester
Actibine, Erex, Testomar, Yocon, Yohimar, Yohimbe
Prescription Only (S4) (AU)
Urine (as metabolites)
354.44 g/mol (base),
390.90 g/mol (hydrochloride)
Y (what is this?) (verify),
Yohimbine is a mild MAOI with stimulant and aphrodisiac effects. It is sold as prescription medicine in pure form for the treatment of sexual dysfunction. Yohimbine was explored as a remedy for type 2 diabetes in animal and human models carrying polymorphisms of the α2A-adrenergic receptor gene.
Common brand names for Yohimbine are: Erex, Testomar, Yocon, Yohimar, Yohimbe.
3 Medical uses
3.1.1 SSRI side-effects,
3.1.2 Sexual dysfunction
3.1.3 Fat loss,
3.1.4 Other uses,
3.2 Adverse effects,
3.3 Precautions and contraindications,
5.1 Pharmacologic Profile of Yohimbine,
6 See also,
Yohimbine primarily acts as an antagonist of α2 receptors. Additionally, it inhibits the function of monoamine oxidase enzymes, although it is not clear if it is a RIMA, MAOA, or MAOB inhibitor.
RIMAS, like moclobemide (an antidepressant), do not require dietary restrictions. Many people have been supplementing with yohimbine on normal diets (containing tyramine and phenylalanine like most cheeses and fish respectively) with no adverse effects. MAOIs are normally contradicted for use with tyrosine rich food, but recently numerous companies have taken to combining yohimbine with tyrosine in their fat burners, and energy products. However, tyrosine failed to potentiate the effect of yohimbine except for somewhat augmenting the increase in DHPG.
When yohimbine are used in pharmahuasca it does not have any MAOI effects on tryptamines, e.g. DMT keeps being orally inactive. This suggest that yohimbine is a MAOB inhibitor. A range of cacti contain tyramine, including the Echinopsis pachanoi (syn. Trichocereus pachanoi), known as the San Pedro cactus which also contain the phenylethylamine mescaline. Poly drug use with yohimbine and mescaline cactus are inconclusive.
Overdoses of yohimbine can cause priapism. Normally priapism is treated with pseudoephedrine but in combination with MAOIs like yohimbine it can lead to hypertensive reactions. The first step in management may be blood exchange transfusion.
MAOI and SSRI are normally never mixed as a rule of thumb. However, yohimbine, with its weak MAOI activity, has safely been used to treat sexual side-effects caused by some SSRI antidepressants (see below for more information about sexual dysfunction). Also, 14 mg yohimbine increases salivation so yohimbine could have a potential interest in the treatment of dry mouths, another common side-effect caused SSRIs. In fact, doctors believe that heartburn (another common SSRI side-effect) is caused by dry mouth because it reduces the amount of saliva running down the esophagus which is known to neutralize excess acid in the stomach.
Main article: http://en.wikipedia.org/wiki/Sexual_dysfunction
The NIH states that yohimbine hydrochloride is the standardized form of yohimbine that is available as a prescription medicine in the United States, and has been shown in human studies to be effective in the treatment of male impotence. Yohimbine has been shown to be effective in the treatment of orgasmic dysfunction in men. Yohimbine has also been used to treat hypoactive sexual desire disorder (reduced libido) in women.
Large doses of yohimbe have caused priapism. However, controlled studies suggest that it is not always an effective treatment for impotence, and evidence of increased sex drive (libido) is anecdotal only.
It cannot be excluded that orally administered yohimbine can have a beneficial effect in some patients with ED. The conflicting results available may be attributed to differences in drug design, patient selection, and definitions of positive response. Generally, however, available results of treatment are not impressive.
Yohimbine blocks the pre- and post-synaptic α2 receptors. Blockade of post-synaptic α2 receptors causes minor corpus cavernosum smooth muscle relaxation. In fact the majority of adrenoceptors in the corpus cavernosum are of the α1 type. Blockade of pre-synaptic α2 receptors facilitates the release of several neurotransmitters, in the central and peripheral nervous system, thus in the corpus cavernosum, such as nitric oxide and norepinephrine. Whether nitric oxide released in the corpus cavernosum is the major vasodilator contributing to the erectile process, norepinephrine is the major vasoconstrictor through stimulation of α1 receptors on the corpus cavernosum smooth muscle. Under physiologic conditions nitric oxide attenuates norepinephrine vasoconstriction. Continuous administration of yohimbine, opposed to on demand administration, might result in less norepinephrine output due to increased turnover, or α1 receptors down regulation via a feedback mechanism, not causing the vasoconstriction due to excessive norepinephrine release which can be seen often with on demand administration. α1 blockers prevent vasoconstriction caused by norepinephrine as well.
Anorgasmia or reduced libido: 5.4-16.2 mg a day 1-2 hours before sexual activity. or 5.4 mg three times a day,
Erectile dysfunction: A suggested first line treatment for mild to moderate ED are a combination of 6 mg yohimbine hydrochloride and 6000 mg arginine glutamate (50% arginine, 50% glutamic acid). Other doses of yohimbine alone to treat ED are 15 to 30 mg a day 1-2 hours before sexual activity.,
According to one study, oral yohimbine supplementation may actuate significant fat loss in athletes, though this study is self-reported and did not monitor caloric intake. Numerous bodybuilding supplement companies sell formulations of yohimbine for transdermal delivery to effect a local reduction of adipose tissue, although the experimental evidence for its efficacy is limited.
Yohimbine has also been used as a blood pressure boosting agent in autonomic failure, xerostomia, and as a probe for noradrenergic activity.
The addition of yohimbine to fluoxetine or venlafaxine has also been found to potentiate the antidepressant action of both of these agents.
Yohimbine has been used to facilitate recall of traumatic memories in the treatment of post traumatic stress disorder (PTSD). Use of yohimbine outside therapeutic settings may not be appropriate for persons suffering from PTSD. In pharmacology, yohimbine is used as a probe for α2-adrenoceptor. In veterinary medicine, yohimbine is used to reverse anesthesia from the drug xylazine in small and large animals.
Depending on dosage yohimbine can both lower and increase systemic blood pressure, known as vasodilation and vasoconstriction respectively; small amounts of yohimbine can increase blood pressure while large amounts can dangerously lower blood pressure.
The therapeutic index of yohimbine is quite low; the range between an effective dose and a dangerous dose is very narrow. A typical dose for sexual dysfunction would be 15-30 mg, whereas 100 mg would be considered dangerous. This may also lead to the precipitation of panic disorder type reactions, heart attack and possibly death.
Hallucinations or paralysis may occur with doses greater than 40 mg. Higher doses of oral yohimbine may create numerous side effects, such as rapid heart rate, overstimulation, insomnia and/or sleeplessness. Some effects in rare cases were panic attacks, hallucinations, headaches, dizziness and skin flushing.
More serious adverse effects may include seizures and renal failure. Yohimbine should not be consumed by anyone with liver, kidney, heart disease, or a psychological disorder.
Precautions and contraindications:
Yohimbe bark is on the FDA list of dangerous supplements. The levels of yohimbine that are present in yohimbe bark extract are variable and often very low. Therefore, although yohimbe bark has been used traditionally to reduce male erectile dysfunction, there is not enough scientific evidence to form a definitive conclusion in this area.
In Africa, yohimbe has traditionally been used as an aphrodisiac. However, it is very important to note that while the terms yohimbine, yohimbine hydrochloride, and yohimbe bark extract are related, they are not interchangeable.
Yohimbine is an alkaloid naturally found in Pausinystalia yohimbe (Yohimbe), Rauwolfia serpentina (Indian Snakeroot), and Alchornea floribunda (Niando), along with several other active alkaloids. Yohimbine has been used as both an over-the-counter dietary supplement in herbal extract
In addition to the main active chemical, yohimbine, Pausinystalia yohimbe contains approximately 55 other alkaloids, of which yohimbine accounts for 1% to 20% of total alkaloids. Among them corynanthine is an α1 receptor blocker. Hence the use of Yohimbe extract in sufficient dosages may provide concomitant α1 and α2 receptors blockade and thus may better enhance erections than yohimbine alone.
Pausinystalia yohimbe is currently threatened with extinction in its native habitat due to international demand. Its conservation is difficult because the bioactivity of the tree has led many Western governments to declare it a proscribed species.
At least 14 days should elapse between discontinuation of MAOI therapy and initiation of treatment with yohimbine.
Yohimbine in combination with norepinephrine reuptake inhibitor, such as dextromethorphan, tramadol, some antidepressants and central nervous system stimulants used to treat ADHD, can cause a hypertensive crises. This is due to those drugs in combination with an a2 receptor antagonist leads to too much norepinephrine in the brain, which causes blood pressure to spike to dangerous levels.
Yohimbine in combination with modafinil is frequently associated with nausea, dangerous acute rapid heart beat, and acute increased blood pressure. Yohimbine exhibits some degree of MAOI activity while modafinil has been shown to increase levels of various monamines and therefore could result in severe risk of dangerous side effects.
Research on cats suggests that yohimbine increases the effects of catecholaminergic stimulants, namely amphetamine and modafinil.
Sport supplements with yohimbine as the main ingredient are sold as purported energy boosters.
Yohimbine has high affinity for the α2-adrenergic receptor, moderate affinity for the α1 receptor, 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1F, 5-HT2B, and D2 receptors, and weak affinity for the 5-HT1E, 5-HT2A, 5-HT5A, 5-HT7, and D3 receptors. It behaves as an antagonist at α1-adrenergic, α2-adrenergic, 5-HT1B, 5-HT1D, 5-HT2A, 5-HT2B, and D2, and as a partial agonist at 5-HT1A. Its intrinsic activities at the other sites listed are unclear/unknown, but it is probably mostly antagonistic at them. Yohimbine interact with serotonin and dopamine receptors in high concentrations.
Pharmacologic Profile of Yohimbine:
Binding Affinity (Ki in nM)
Rat and Mouse
Cloned, Cortex & NG108-15
Rat and Mouse